Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BS.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.132 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.4.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDGENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used